A new AI-driven framework enables highly accurate prediction of RNA splicing and isoform usage for therapeutic applications.

An ADC with a novel RNA spliceosome modulating payload PH1 paired with a KRAS inhibitor demonstrates synergistic cytotoxic ...

Akari Therapeutics (AKTX) on Thursday announced promising preclinical data demonstrating that its lead cancer therapy, ...

A new AI-based system combines genomic sequences and RNA-binding protein profiles to model complex RNA splicing patterns ...

Researchers developed HELIX, an AI framework that predicts RNA splicing and isoform usage by integrating DNA and protein data ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with a ...

RNA splicing is a cellular process that is critical for gene expression. After genes are copied from DNA into messenger RNA, portions of the RNA that don't code for proteins, called introns, are cut ...

Cancers driven by hiccups in RNA processing can’t hide from our immune system, according to new work published today in Cell. A cross-institutional team Fred Hutch Cancer Center and Memorial Sloan ...

Alzheimer's Disease (AD), the leading cause of dementia, affects nearly 40 million individuals globally, resulting in a gradual loss of memory and independence. Despite extensive research over the ...

Akari Therapeutics (AKTX) announced on Thursday the pricing of a private placement financing round, expecting to raise an aggregate of approximately $5.5M in gross proceeds. With these funds, the ...